Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine.
about
Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implicationsStructure-Activity Relationships of a Series of Echinocandins and the Discovery of CD101, a Highly Stable and Soluble Echinocandin with Distinctive Pharmacokinetic PropertiesLimitations of caspofungin in the treatment of obstructive pyonephrosis due to Candida glabrata infection.Pharmacokinetics of caspofungin acetate to guide optimal dosing in cats.Relevance of Liver Failure for Anti-Infective Agents: From Pharmacokinetic Alterations to Dosage AdjustmentsCryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins.Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitroHuman pharmacogenomic variations and their implications for antifungal efficacy.Disposition of caspofungin, a novel antifungal agent, in mice, rats, rabbits, and monkeys.Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma.Warfarin treatment and antifungal agent caspofungin for severe fungal infection in a patient previously treated with radiotherapy for oropharyngeal cancer.In vitro and in vivo studies to characterize the clearance mechanism and potential cytochrome P450 interactions of anidulafungin.
P2860
Q27025299-03892232-DCEB-4F86-9AA1-2B2C46500488Q28817906-8A0576CE-6F14-45BF-871E-D3EFE43656E1Q33253245-1CAE64FC-949E-4BC9-8136-B076E04CF1E5Q33757912-45A3F4F7-3502-4BD4-81D9-7AE93BC1EC6DQ33763177-CA8FF736-E09E-4D50-8081-9A9B29B7D47BQ33883762-C0F615D4-AE5D-463D-9902-F51188357B7EQ34112321-B92628B4-4AC1-427E-A7A1-838A776CBB47Q35070838-7D161978-9B14-492A-9C86-82E63C044D18Q37121115-10440808-2262-497F-ADAD-AA811F9854BFQ38681635-99CE4E86-69D3-4C5C-A89D-17A00EE12A80Q40622190-36615538-AB75-47D1-83EA-755F6D2A7B10Q40797535-66C34450-C6AC-448F-977D-79C1EBC8369AQ43169846-910513CE-E97E-49D2-A13E-E84D6465EA45
P2860
Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine.
@ast
Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine.
@en
type
label
Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine.
@ast
Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine.
@en
prefLabel
Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine.
@ast
Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine.
@en
P2093
P1476
Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine.
@en
P2093
B H Arison
F A DeLuna
M A Wallace
P G Pearson
P304
P577
2000-11-01T00:00:00Z